NCT05239533 2026-01-14
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Clinical Trials
1 trialsSingle Photon Emission Computed Tomography Computed Tomography × Genitourinary × 90 days × Clear all